Palisade Bio, Inc. (PALI) — 分析师展望 / 分析师共识目标价为. 基于 3 位分析师评级, 共识为 看涨 — 3 买入.
分析师共识目标价为 $1.50, 下跌空间为 35.9% 相对于当前价格 $2.34.
分析师预估 每股收益(EPS)为 $-11.66 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-2.48 vs 预期 $-11.66 (超预期 +78.7%). 2025: 实际 $-0.30 vs 预期 $-0.54 (超预期 +44.9%). 分析师准确度: 0%.
PALI 股票 — 12个月价格预测
$1.50
▼ -35.90% 下跌空间
平均目标价
Based on 3 Wall Street analysts offering 12-month price targets for Palisade Bio, Inc., the price target is $1.50.
平均目标价相对最新价格 $2.34 变动 -35.90%。
PALI 分析师评级
Buy
基于过去3个月内 3 位分析师对 Palisade Bio, Inc. 的评级
EPS 预测 — PALI
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$2.48
vs Est –$11.66
▲ 370.3% off
2025
Actual –$0.30
vs Est –$0.54
▲ 81.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — PALI
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
